title: Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight.
abstract: Chronic imbalance of the autonomic nervous system is a prevalent and potent risk factor for adverse cardiovascular events, including mortality. Although not widely recognized by clinicians, this risk factor is easily assessed by measures such as resting and peak exercise heart rate, heart rate recovery after exercise, and heart rate variability. Any factor that leads to inappropriate activation of the sympathetic nervous system can be expected to have an adverse effect on these measures and thus on patient outcomes, while any factor that augments vagal tone tends to improve outcomes. Insulin resistance, sympathomimetic medications, and negative psychosocial factors all have the potential to affect autonomic function adversely and thus cardiovascular prognosis. Congestive heart failure and hypertension also provide important lessons about the adverse effects of sympathetic predominance, as well as illustrate the benefits of beta-blockers and angiotensin-converting enzyme inhibitors, 2 classes of drugs that reduce adrenergic tone. Other interventions, such as exercise, improve cardiovascular outcomes partially by increasing vagal activity and attenuating sympathetic hyperactivity.
authors.affiliation: Mid-America Heart Institute of Saint Luke's Hospital and the University of Missouri, Kansas City, USA.
authors.forename: Brian M
authors.initials: BM
authors.lastname: Curtis
authors.forename: James H
authors.initials: JH
authors.lastname: O'Keefe
mesh_terms: D000318:Adrenergic beta-Agonists / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D001341:Autonomic Nervous System / Q000503:physiopathology*; D002318:Cardiovascular Diseases / Q000503:physiopathology* / Q000517:prevention & control / Q000523:psychology; D006329:Heart Conduction System / Q000503:physiopathology*; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D012307:Risk Factors; D013566:Sympathomimetics / Q000009:adverse effects
chemical_list: D000318:Adrenergic beta-Agonists; D000959:Antihypertensive Agents; D013566:Sympathomimetics